To research the best time to provide cardiopulmonary bypass (CPB) and the best way to do it when treating an extensive tumor thrombosis of the inferior vena cava vein (IVC).
Results:
The operating times in groups A and B were (376.7 ± 91.2) and (373.1 ± 80.7) minutes, respectively, with no statistically significant difference (t = 0.716, p > 0.05); intraoperative bleeding was (1916.7 ± 925.1) ml and (2600 ± 3756.3) ml, (t = −0.601, p < 0.05), and hospitalization was (32.3 ± 16.0) and (34.0 ± 8.0) days, with statistically significant differences (p < 0.05).
Conclusion:
The CPB approach has the advantages of less intraoperative blood loss, faster surgical procedures, and fewer hospitalizations.
ChengSYeeLWMengchaoW.The conception and significance of establishing carcinothrombosis. National Med J Chin2020; 100: 1048–1050.
2.
BertiniRRoscignoMFreschiM, et al. Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma. Eur Urol2011; 60(2): 358–365.
3.
AbelEJMastersonTAKaramJA, et al. Predictive nomogram for recurrence following surgery for nonmetastatic renal cell cancer with tumor thrombus. J Urol2017; 198(4): 810–816.
4.
AbelEJSpiessPEMargulisV, et al. Cytoreductive nephrectomy for renal cell carcinoma with venous tumor thrombus. J Urol2017; 198(2): 281–288.
5.
NooromidMJJuMHHavelkaGE, et al. Fifteen-year experience with renal cell carcinoma with associated venous tumor thrombus. Surgery2016; 160(4): 915–923.
6.
TorreWTamuraARabagoG, et al. Can the opportunity of cardio-pulmonary bypass be useful in complex general thoracic surgery problems? A report of nine cases. J Cardiovasc Surg2012; 53(3): 381–386.
7.
YuanS-MShinfeldARaananiE.Cardiopulmonary bypass as an adjunct for the noncardiac surgeon. J Cardiovasc Med2008; 9(4): 338–355.
8.
LangGTaghaviSAignerC, et al. Extracorporeal membrane oxygenation support for resection of locally advanced thoracic tumors. Ann Thorac Surg2011; 92(1): 264–270.
9.
KomarovRNRapoportLMOgnevOO, et al. Resection of the inferior vena cava in patients with kidney tumor and tumor thrombus. Androl Genit Surg2023; 23(4): 90–95.
10.
WenboLZhankuiJChaohuiG, et al. Surgical comparison of renal cell caricinoma with III,IV tumor thrombus in inferior vena cava with or without the aid of cardiopulmonary bypass. Chin J Exp Surg2015; 32(5): 1181–1183.
11.
ZiniLKoussaMHaulonS, et al. Results of endoluminal occlusion of the inferior vena cava during radical nephrectomy and thrombectomy. Eur Urol2008; 54(4): 778–784.
12.
AmirghofranAAEmaminiaARayatpishehS, et al. Intracardiac invasive thymoma presenting as superior vena cava syndrome. Ann Thorac Surg2009; 87(5): 1616–1618.
13.
TovedalTMyrdalGJonssonO, et al. Experimental treatment of superior venous congestion during cardiopulmonary bypass. Eur J Cardio-Thorac Surg2013; 44(3): e239–e44.
14.
WotkowiczCLibertinoJASorciniA, et al. Management of renal cell carcinoma with vena cava and atrial thrombus: minimal access vs median sternotomy with circulatory arrest. BJU Int2006; 98(2): 289–297.
